Medicaments for the treatment of restenosis and arterial scleros

Details Medicaments for the treatment of restenosis and arterial scleros Medicaments for the treatment of restenosis and arterial scleros

1995-11-09

1997-01-21

Jordan, Kimberly

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514822, 514824, A61K 3800

Patent

active

055959741

ABSTRACT:
A medicament for the treatment and/or prophylaxis of restenosis and arterial sclerosis after percutaneous transluminal angioplasty, characterized in that the medicament contains batroxobin as an effective component.

REFERENCES:
Journal of Biological Chemistry, vol. 262, No. 7, pp. 3132-3135, Mar. 5, 1987, N. Itoh, et. al., "Molecular Cloning and Sequence Analysis of cDNA for Batroxobin, A Thrombin-like Snake Venom Enzyme".
Medicine and Pharmacy, vol. 14, No. 4, pp. 1061-1071, Oct. 1985, Shizen Kagakusha.
Merck Index, 11th Ed., 1989, #1020, #4571.

Affiliated with

Also associated with

Rating

Medicaments for the treatment of restenosis and arterial scleros does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicaments for the treatment of restenosis and arterial scleros, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicaments for the treatment of restenosis and arterial scleros will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2324267